Streamlining Medicare Tezspire Prior Authorization Workflows

Navigating Medicare Tezspire prior authorization presents distinct challenges across Original Medicare and Medicare Advantage Part D plans. Klivira streamlines these complex processes, ensuring efficient submission and tracking.

For revenue cycle directors and prior authorization coordinators, managing prior authorizations for high-volume biologics like Tezspire (tezepelumab) under Medicare requires a nuanced approach. The federal Medicare program, encompassing Original Medicare (Parts A and B) and privately administered Medicare Advantage (Part C) with Part D prescription drug plans, each have unique PA requirements that impact patient access to critical therapies for severe asthma.

Understanding Tezspire and its Medicare Coverage Landscape

Tezspire (tezepelumab) is a high-volume biologic indicated for the treatment of severe asthma. As a prescription medication, its coverage primarily falls under Medicare Part D, which is administered by private insurance plans. While Original Medicare's prior authorization scope is limited, Medicare Advantage plans and their associated Part D formularies often mandate prior authorization for specialty drugs like Tezspire, necessitating a precise understanding of plan-specific requirements.

Navigating Prior Authorization for Tezspire in Medicare Part D

Medicare Part D plans, operated by commercial insurers, administer pharmacy prior authorization per CMS-approved plan formularies and step-therapy protocols. For Tezspire, this means navigating diverse requirements that can vary significantly between plans, impacting formulary tiers, step therapy criteria, and quantity limits. Klivira integrates with these Part D plan portals and associated PBMs to automate the submission of NCPDP SCRIPT transactions and manage ePA workflows.

Original Medicare (Part A/B) and Limited PA Scope for Biologics

The prior authorization scope under Original Medicare (Parts A and B) is generally limited, particularly for prescription drugs that fall under Part D. While the drug itself is a Part D benefit, if Tezspire administration requires specific outpatient department services, DME, or other services covered under Part A or B, these may be subject to PA through the responsible Medicare Administrative Contractor (MAC). Klivira's MAC-aware routing handles per-jurisdiction submission specifics where such medical PAs are required.

Key Medicare Administrative Contractors (MACs) and Their Role

  • Noridian: Manages claims and PA for specific regions.
  • NGS: Handles Medicare claims for various states.
  • WPS: Serves multiple jurisdictions for Medicare Part A and B.
  • Palmetto: Covers a range of states for Medicare services.
  • FCSO: Responsible for specific regional Medicare operations.
  • Novitas: Processes claims and PAs in several jurisdictions.

Policy and Coverage Determinations Affecting Tezspire

Coverage for Tezspire under Medicare is influenced by several policy documents. CMS publishes National Coverage Determinations (NCDs), and MACs publish Local Coverage Determinations (LCDs) specific to their jurisdictions. While Part D plans have their own formularies, NCDs and LCDs can impact coverage for related medical services or provide clinical context for Part D coverage decisions. Klivira's platform incorporates NCD/LCD-aware policy logic to assist in generating compliant prior authorization requests.

Streamlining Medicare Tezspire Prior Authorization with Klivira

Klivira provides a robust solution for managing Medicare Tezspire prior authorization. Our platform integrates with various payer portals, including those of Medicare Advantage Part D plans and PBMs, to automate the submission of ePA requests. For instances where Original Medicare (Part A/B) PA is required for associated services, Klivira routes submissions through the appropriate MAC jurisdiction, leveraging NCD/LCD-aware policy logic to enhance accuracy and reduce manual effort.

Frequently asked questions

Is Tezspire (tezepelumab) typically covered under Original Medicare?

As a prescription biologic, Tezspire primarily falls under Medicare Part D coverage, which is administered by private insurance plans. Original Medicare (Parts A and B) has a limited prior authorization scope and typically does not cover outpatient prescription drugs directly.

How do Medicare Administrative Contractors (MACs) impact Tezspire prior authorization?

MACs handle prior authorizations for specific medical services covered under Original Medicare Parts A and B. While they do not typically manage PA for Part D drugs like Tezspire directly, they would be involved if the administration of Tezspire or related medical services required a Part A/B prior authorization.

What are common reasons for Tezspire PA denials under Medicare Part D?

Common reasons for denial under Medicare Part D plans include failure to meet specific formulary criteria, lack of documented step-therapy completion, not meeting quantity limits, or insufficient clinical documentation to support medical necessity as per the plan's policies. Each Part D plan has unique requirements.

Does the CMS-0057-F rule apply to Tezspire prior authorizations?

The CMS-0057-F rule primarily affects Medicare Advantage, Medicaid managed care, CHIP, and QHP-on-FFM lines. Its applicability to Traditional Medicare is limited. For Tezspire, the rule would largely apply to its prior authorization processes under Medicare Advantage Part D plans, not Original Medicare.

How does Klivira help with Tezspire prior authorization for Medicare patients?

Klivira automates the submission of prior authorization requests for Tezspire to Medicare Part D plans and their PBMs, integrating with their portals. For any associated Part A/B services requiring PA, Klivira routes requests through the relevant MACs, applying NCD/LCD-aware policy logic to streamline the process and reduce manual burdens.

Related coverage

Other tezspire prior authorization by payer

Other tezspire prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo